The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing result 1 - 1 of 1
Recommendations of the Swiss Federal Commission for Sexual Health (FCSH) on PrEP for HIV Prevention
In Switzerland, HIV drugs are not approved for prophylactic use. Physicians who prescribe oral chemoprophylaxis for HIV prevention do so on an off-label basis and are thus liable for any adverse effect that may occur. Nonetheless, the protective effects of oral PrEP are comparable to those of condom use, despite the higher price. The FCSH therefore…